To Reduce Incidences of Preventable Cytotoxic Drug Extravasation in Ambulatory Treatment Unit
Care Process & Redesign
Singapore Healthcare Management Congress
SingHealth
31 December 2018
Reduce incidences of preventable cytotoxic drug extravasation in the Ambulatory Treatment Unit (ATU) by 33% from 3. Enhanced preventive strategies led to zero preventable cases, supporting patient safety in chemotherapy.
Year Submitted: 2018
Published Date: 31 December 2018
Tags: Care Process ＆ Redesign, Value Based Care, Safe Care, Risk Management, Preventive Approach
About this Content
Aims
Reduce incidences of preventable cytotoxic drug extravasation in the Ambulatory Treatment Unit (ATU) by 33% from 3 cases/month to 2 cases/month.
Background
Extravasation of cytotoxic drugs causes severe tissue damage, impacting patient outcomes and increasing costs.
Methods
Identified risk factors, implemented three PDSA cycles, and developed risk mitigation strategies including patient education, cannula assessment, and nurse training.
Results
Reduced preventable cases to 0 cases/month; increased patient safety and nurse confidence.
Conclusion
Enhanced preventive strategies led to zero preventable cases, supporting patient safety in chemotherapy.
Lessons Learnt
Proactive monitoring, patient education, and clear guidelines reduce extravasation risks.
Additional Information
Recognized at the Singapore Healthcare Management Conference 2018 for safe care and risk management improvements.
Keywords
Cytotoxic Drugs, Extravasation Prevention, Risk Factors
Innovators' Details
Innovators' Details
Healthcare Cluster(s) | SingHealth |
Organization(s) Involved | National Cancer Centre Singapore |
Platform(s) | Singapore Healthcare Management Congress |
Healthcare Professional Group(s) | Nursing, Medical, Pharmacy |
Applicable Specialty or Discipline | Oncology |
Project Lead(s) | Peggy Cheng |
Project Member(s) | Justina Lam |
Connect with this contributor!
Peggy Cheng - singaporehealthcaremanagement@singhealth.com.sg
Project Attachment
C271_NCCS_To_Reduce_Incidences_of_Preventable_Cytotoxic_Drug.pdf